These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34091677)

  • 21. Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy.
    Sheaffer WW; Gray RJ; Wasif N; Stucky CC; Cronin PA; Kosiorek HE; Basu A; Pizzitola VJ; Patel B; Giurescu ME; Lorans R; McCullough AE; Ocal IT; Pockaj BA
    Am J Surg; 2019 Jun; 217(6):1025-1029. PubMed ID: 30879795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
    Venkatesh SL; Oseni TO; Bahl M
    Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision.
    Walters LL; Pang JC; Zhao L; Jorns JM
    Histopathology; 2015 Mar; 66(4):577-86. PubMed ID: 25231210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Surgical Upstaging Risk of Ductal Carcinoma In Situ Using Machine Learning Models.
    Hashiba KA; Mercaldo S; Venkatesh SL; Bahl M
    J Breast Imaging; 2023; 5(6):695-702. PubMed ID: 38046928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
    Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
    Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
    Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
    Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
    Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
    Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
    Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast.
    Kim S; Kim J; Park HS; Kim HY; Lee K; Lee J; Lee H; Kim JY; Kim SI; Cho YU; Park BW
    Yonsei Med J; 2019 Nov; 60(11):1028-1035. PubMed ID: 31637884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concordance between vacuum assisted biopsy and postoperative histology: implications for the proposed Low Risk DCIS Trial (LORIS).
    Soumian S; Verghese ET; Booth M; Sharma N; Chaudhri S; Bradley S; Umranikar S; Millican-Slater RA; Hanby AM; Francis A
    Eur J Surg Oncol; 2013 Dec; 39(12):1337-40. PubMed ID: 24209431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Prospective Validation of a Risk Calculator That Predicts a Low Risk Cohort for Atypical Ductal Hyperplasia Upstaging to Malignancy: Evidence for a Watch and Wait Strategy of a High-Risk Lesion.
    Lustig DB; Guo M; Liu C; Warburton R; Dingee CK; Pao JS; Kuusk U; Chen L; McKevitt EC
    Ann Surg Oncol; 2020 Nov; 27(12):4622-4627. PubMed ID: 32710273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial for "Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics".
    Grøvik E; Hoff SR
    J Magn Reson Imaging; 2023 Aug; 58(2):464-465. PubMed ID: 36625489
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed.
    Le Gac M; Dabi Y; Ilenko A; De Foucher T; Ferrier C; Zilberman S; Sussfeld J; Touboul C; Daraï E; Bendifallah S
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():7-14. PubMed ID: 35131632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
    Mustafa RE; DeStefano LM; Bahng J; Yoon-Flannery K; Fisher CS; Zhang PJ; Tchou J; Czerniecki BJ; De La Cruz LM
    Ann Surg Oncol; 2017 Oct; 24(10):2999-3003. PubMed ID: 28766212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.